Return to Previous Page
Details
The tetrapeptide LSKL prevents hepatic fibrosis in vivo via blocking TGFβ1 activation. The analog LSAL has been used as inactive control.
Catalog Number
H-4756
APC Number
51-0-00
One Letter Code
LSKL
Molecular Formula
C₂₁H₄₁N₅O₆
Relative Molecular Mass
459.59
CAS Registry Number
162559-45-7
Source
Synthetic
Storage Conditions
-20 ± 5 °C
Application
Growth Factors
Hematology
Hematology
Links / Documents:
